Psychedelic Healing Sonia Cotto

The discourse of integrating psychedelics into leadership and entrepreneurship is blazing new trails. As we traverse this illuminating path, key insights from thought leaders like Jackson Strong, CEO of AUREA, offer innovative perspectives on how the ancient wisdom of psychedelics is harmonizing with the burgeoning era of purpose-driven leadership. Through his journey from a successful tech entrepreneur to a spiritual guide for modern-day changemakers, Strong illuminates the potential of psychedelics to catalyze deeper connections with life and elevate our collective consciousness.
The episodes starts with an exploration into what Jackson Strong refers to as "the new golden age". Strong describes this not merely as a phrase but as an alignment of numerous cosmic and prophetic cycles — a crescendo of time and philosophy where catastrophic global events coincide with a massive resurgence in spirituality and self-discovery, often facilitated by psychedelics. Strong's metamorphosis from a tech entrepreneur to a catalyst in spiritual entrepreneurship and leadership is deeply telling of how one’s personal growth journey can have a broader communal impact. He describes this evolution with candor, detailing his own ventures and psychedelic experiences that led him to realize his true callings beyond the corporate sphere.

The intriguing realm of psychedelic therapy opens doors to potential healing and consciousness expansion beyond traditional medical approaches. In a candid conversation, Shannon Stark, a board-certified psychiatric nurse practitioner and a trailblazer in ketamine psychotherapy, reveals how combining this psychedelic with integrative practices ushers in a new era of mental health treatment.
Ketamine stands out in its potential as a therapeutic agent, especially when coupled with integration and intentionality. According to Stark, "the results and the experiences and the possibilities consistently seen with my clients is quite extraordinary", emphasizing ketamine's role in facilitating deep shifts in mental health conditions. This episode offers an insightful exploration into how ketamine, when administered in a controlled and supportive setting, becomes a powerful lever for neuroplasticity and insight.

Psychedelics have emerged as a frontier of hope in mental health, offering transformative experiences for those grappling with traumas that defy traditional therapies. As we delve into the heartrending journey of Alex Abraham, a survivor of childhood sexual abuse, we encounter a narrative that challenges our understanding of healing and confronts the potential of psychedelics in catalyzing profound personal change.
The journey of healing with psychedelics often begins with the introspection and revelation of memories long buried within the psyche. For Alex, MDMA-assisted psychotherapy was the key that unlocked his childhood experiences of sexual abuse. This radical encounter with his past was not without its challenges. As Abraham's experience highlights, the somatic effects of trauma often manifest as physical ailments — an area where psychedelics have shown promising results.

The entwined paths of modern psychiatry and the reemergence of psychedelics have led to revolutionary approaches to mental health care. Through the shared journey of psychedelic research and therapy, we are rediscovering ancient wisdom and combining it with contemporary science to unlock the potential for healing that lies within our own minds. From combating long-term mental illness to mitigating everyday stress, psychedelics, alongside innovative technologies, are offering new avenues for lasting wellness.
In this episode of Psychedelic Healing we speak with Dr. Dave Rabin, a psychiatrist and neuroscientist. We discuss the transformative power of psychedelic-assisted psychotherapy and the importance of creating a safe and healing environment for patients. Dr. Rabin also introduces Apollo Neuroscience, a wearable technology that uses touch therapy to induce a state of calm and relaxation. We explore the integration of Apollo with psychedelic treatments, highlighting the potential for enhanced experiences and improved outcomes.

In a revealing and profound discussion, Daniel Carcillo, a former professional athlete turned mental health advocate, speaks with us about his odyssey through the trials of post-concussion syndrome and traumatic brain injury to find redemption in psychedelic medicine. As a two-time Stanley Cup winner with the Chicago Blackhawks, Carcillo's endorsement of psychedelics offers a unique peek into the future of mental health treatment and its intersection with personal resilience and revolutionary medical therapies.
Psychedelic medicine is proving to be a substantial ally in the fight against mental health challenges, especially those related to traumatic brain injuries (TBI) and post-concussion syndrome. As Carcillo narrates, his salvation came in the form of psilocybin, a substance traditional pharmaceuticals failed to parallel in effectiveness. His recovery is not just an anecdote but a testament that calls for a broader acceptance and understanding of psychedelic therapy.

The exploration of psychedelics in mental health is a burgeoning field, daring to reshape the landscape of traditional therapy. At the forefront of this paradigm shift are clinicians pioneering an integrative approach to addiction and chronic pain management. Through a fusion of pharmacology with holistic measures trailblazers, such as Dr. Howard Kornfeld and Inna Zelikman of Recovery Without Walls, are unlocking transformative healing possibilities within psychedelic-assisted therapies.
In Part two of our conversation we lead further into the nuance of dosing - a cornerstone for the efficacy of ketamine-assisted therapy. Kornfeld and Zelikman describe their methodical process, a precise titration starting from 0.5 milligrams per kilogram and adjusting according to individual responses. "We can, you know, set the right dose for a patient to have that psychedelic experience," Ina Zelikman explains, shedding light on the careful personalization that dictates the journey's course. This emphasis on individualization underscores the critical role of the patient-clinician dynamic and the imperative of adapting each treatment to unique physiological and psychological landscapes.